Prognostic Value of Nuclear Morphometry in Patients With TNM Stage T1 Ovarian Clear Cell Adenocarcinoma

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6690276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry

Frontiers in Oncology
Cancer ResearchOncology
2020English

Prognostic Value of Histological Type in Stage IV Ovarian Carcinoma: A Retrospective Analysis of 223 Patients

British Journal of Cancer
Cancer ResearchOncology
2015English

Napsin a Is a Specific Marker for Ovarian Clear Cell Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2014English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

High-Level Expression of Notch1 Increased the Risk of Metastasis in T1 Stage Clear Cell Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2012English

P1.09-27 Clear Cell Adenocarcinoma Subtype Is an Independent Predictor of Better Survival in Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Hypoxia Inducible Factor-1α Expression in Patients With Clear Cell Renal Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy